Fuji Medical USA has integrated 3D directly into its Synapse PACS, eliminating the need for thin-client 3D or dedicated 3D workstations accompanying its PACS. The newly integrated technology, dubbed Synapse 3D, was shown for the first time as a commercial product at RSNA 2010, accompanied by a work-in-progress application called Synapse Mobility that promises to allow access to Synapse PACS images and clinical tools using handheld devices.
Fuji Medical USA has integrated 3D directly into its Synapse PACS, eliminating the need for thin-client 3D or dedicated 3D workstations accompanying its PACS. The newly integrated technology, dubbed Synapse 3D, was shown for the first time as a commercial product at RSNA 2010, accompanied by a work-in-progress application called Synapse Mobility that promises to allow access to Synapse PACS images and clinical tools using handheld devices.
The key advantage of Synapse 3D is simplicity. It provides access to advanced visualization without the need for separate workstations. The new product offering is vendor-neutral and capable of handling data from any digital modality. Clinical tools address 2D, 3D, and 4D processing, dynamic imaging, fusion, and multiplanar reconstruction. Synapse 3D is also directly integrated into the company’s cardiovascular imaging system, Synapse Cardiovascular, although this is not yet FDA-cleared.
Synapse 3D is available at any workstation connected to Synapse PACS, including remote locations, such as home. It can be accessed with a single click from the Synapse power jacket or through “quick launch” mode.
A future complement to Synapse PACS and its 3D capability is Fuji’s work-in-progress Synapse Mobility, also shown at RSNA 2010. In final form, the zero-footprint application will provide access to the same high-quality interactive images that can be seen at a Synapse PACS workstation, according to Jim Morgan, Fujifilm vice president of medical informatics. Synapse Mobility is being developed to display interactive 3D images, not just static flash files, on iPads, iPhones, and Android Smartphones, as well as Macintosh- or Windows-based PCs. Images will be manipulated using zoom, window and level, and MIP/MPR with access to Synapse PACS, Synapse RIS, and Synapse Cardiovascular.
Fuji expects to begin selling Synapse Mobility in the first quarter of 2011 with downloads through the Apple Store.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.